New York, NY -- (SBWIRE) -- 02/01/2014 -- To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
StockMarketIntel.com issues a special report on the following stocks: Life Technologies Corp. (NASDAQ:LIFE), Eli Lilly & Co. (NYSE:LLY), Bristol-Myers Squibb Co (NYSE:BMY), Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)
Life Technologies Corp. (NASDAQ:LIFE) gained 0.14%, trading on 8.46 million shares, to end the trade at $76.07. The stock changed hands in a range of $75.96 to $76.09, bringing its market capitalization to about $13.15 billion. If we look at its trading history of the past 52 weeks, the share price suffered a low of $56.67 and was moved to the maximum level of $76.09. Life Technologies Corporation (Life Technologies) is a global life sciences company. The Company's systems, consumables and services enable scientific researchers and commercial markets to accelerate scientific exploration, to discoveries and developments that improve the quality of life.
Why Should Investors Buy LIFE After The Recent Gain? Just Go Here and Find Out
Eli Lilly & Co. (NYSE:LLY) added 1.39%, to complete the trading session at $54.01, with a total volume of 8.21 million shares. The stock, on average, trades on a volume of 5.55 million shares. It floated in a range of $52.87 to $54.06 during the last trading session, with a beta value of 0.61. Its market capitalization now moved to about $60.85 billion. In the past 52 weeks, the share price has not declined below $47.53 and above $58.40. Eli Lilly and Company discovers, develops, manufactures, and sells products, in one business segment, pharmaceutical products. The Company also has an animal health business segment. It manufactures and distributes its products through facilities in the United States, Puerto Rico, and 15 other countries.
What was the Moving Force behind LLY on Bullish Run? Read This Research Report
Bristol-Myers Squibb Co (NYSE:BMY) recorded a fall of -1.03% and was in a range of $49.76-$50.47 before closing at $49.97. The stock completed the day with a total volume of 7.73 million shares, versus an average volume of 9.29 million shares. The share price hit its 52-week low of $35.77 and $56.83 was the best price. Bristol-Myers Squibb Company (BMS) is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. It operates in BioPharmaceuticals. Its products are sold worldwide, primarily to wholesalers, retail pharmacies, hospitals, government entities and the medical profession.
Will BMY Get Buyers Even After The Recent Rally? Find Out Here
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) added 1.30% yesterday, bringing its market capitalization around $439.11 million. The share price, after opening at $13.21, made a high of $15.59 and hovered above $12.60 to end the day at $13.23. The total number of shares that changed hands during the session was 7.66 million shares, as compared to average trading volume of 943,292 shares. Vanda Pharmaceuticals Inc. (Vanda) is a biopharmaceutical company. The Company is focused on the development and commercialization of products for the treatment of central nervous system disorders. The Company’s product portfolio includes tasimelteon, a compound for the treatment of circadian rhythm sleep disorders (CRSD), which is in clinical development for Non-24, Fanapt, a compound for the treatment of schizophrenia, the oral formulation of which is being marketed and sold in the United States by Novartis Pharma AG (Novartis), and VLY-686, a small molecule neurokinin-1 receptor (NK-1R) antagonist.
For How Long VNDA will fight for Profitability? Read This Trend Analysis report
To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)